Joint Past Earnings Performance
Past criteria checks 0/6
Joint's earnings have been declining at an average annual rate of -10.5%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 23.6% per year.
Key information
-10.5%
Earnings growth rate
-10.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 23.6% |
| Return on equity | -39.4% |
| Net Margin | -8.3% |
| Next Earnings Update | 02 May 2024 |
Recent past performance updates
Recent updates
The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up
Mar 10
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Feb 12Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jun 17Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher
Jan 04Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Oct 27The Joint Corp. Can Relieve You From High Inflation Pain
Oct 17The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape
Aug 05These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well
Jul 22Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jun 29Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?
Jun 14Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Mar 03Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?
Feb 23Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Feb 08Joint Corp.: Solid Q4 Results From This Small-Cap Growth Story
Jan 30Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jan 24What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?
Jan 08Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?
Nov 23Is Joint (NASDAQ:JYNT) A Risky Investment?
Nov 08Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Oct 21Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?
Oct 05The Joint Corporation: Time To Take Some Profits
Aug 10Is Joint (NASDAQ:JYNT) Using Too Much Debt?
Aug 02The Joint Corp. Has Rallied By 400% Since We Bought, But It's Time To Let It Go
Jul 23Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jul 15Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?
Jun 04We Discuss Whether The Joint Corp.'s (NASDAQ:JYNT) CEO Is Due For A Pay Rise
May 22Revenue & Expenses BreakdownBeta
How Joint makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 118 | -10 | 98 | 0 |
| 30 Sep 23 | 115 | 2 | 95 | 0 |
| 30 Jun 23 | 112 | 4 | 92 | 0 |
| 31 Mar 23 | 107 | 3 | 90 | 0 |
| 31 Dec 22 | 101 | 1 | 84 | 0 |
| 30 Sep 22 | 95 | 0 | 82 | 0 |
| 30 Jun 22 | 89 | 2 | 76 | 0 |
| 31 Mar 22 | 85 | 5 | 69 | 0 |
| 31 Dec 21 | 80 | 8 | 62 | 0 |
| 30 Sep 21 | 76 | 18 | 55 | 0 |
| 30 Jun 21 | 70 | 17 | 50 | 0 |
| 31 Mar 21 | 63 | 15 | 46 | 0 |
| 31 Dec 20 | 59 | 13 | 44 | 0 |
| 30 Sep 20 | 56 | 4 | 43 | 0 |
| 30 Jun 20 | 53 | 3 | 41 | 0 |
| 31 Mar 20 | 51 | 3 | 40 | 0 |
| 31 Dec 19 | 48 | 3 | 37 | 0 |
| 30 Sep 19 | 45 | 2 | 35 | 0 |
| 30 Jun 19 | 41 | 2 | 33 | 0 |
| 31 Mar 19 | 39 | 1 | 31 | 0 |
| 31 Dec 18 | 37 | 0 | 30 | 0 |
| 30 Sep 18 | 34 | -1 | 28 | 0 |
| 30 Jun 18 | 31 | -1 | 26 | 0 |
| 31 Mar 18 | 28 | -2 | 24 | 0 |
| 31 Dec 17 | 25 | -3 | 23 | 0 |
| 30 Sep 17 | 24 | -9 | 23 | 0 |
| 30 Jun 17 | 23 | -11 | 25 | 0 |
| 31 Mar 17 | 22 | -13 | 26 | 0 |
| 31 Dec 16 | 21 | -15 | 26 | 0 |
| 30 Sep 16 | 19 | -13 | 26 | 0 |
| 30 Jun 16 | 17 | -12 | 24 | 0 |
| 31 Mar 16 | 16 | -10 | 21 | 0 |
| 31 Dec 15 | 14 | -9 | 19 | 0 |
| 30 Sep 15 | 12 | -8 | 15 | 0 |
| 30 Jun 15 | 10 | -7 | 12 | 0 |
| 31 Mar 15 | 8 | -5 | 9 | 0 |
| 31 Dec 14 | 7 | -3 | 6 | 0 |
| 30 Sep 14 | 7 | 0 | 5 | 0 |
| 30 Jun 14 | 6 | 0 | 4 | 0 |
| 31 Mar 14 | 6 | 0 | 4 | 0 |
| 31 Dec 13 | 6 | 0 | 3 | 0 |
Quality Earnings: JYNT is currently unprofitable.
Growing Profit Margin: JYNT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: JYNT is unprofitable, and losses have increased over the past 5 years at a rate of 10.5% per year.
Accelerating Growth: Unable to compare JYNT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: JYNT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.3%).
Return on Equity
High ROE: JYNT has a negative Return on Equity (-39.37%), as it is currently unprofitable.